Issue 3, 2024

Synthesis of new alendronate analogs for bone-targeted drug delivery strategies

Abstract

1-Hydroxymethylene-1,1-bisphosphonate (HMBP) derivatives are widely used for the treatment of bone disorders and for bone imagery. Through their high affinity for bone matrix hydroxyapatite, they have shown promising development as powerful bone vectors for many bioactive compounds. To improve the toolbox of conjugatable bisphosphonates, we reported here a convenient synthesis of alendronate derivatives bearing tunable functions on their side chain. The developed straightforward synthetic strategy provides substituted 1-aminoalkyl-1-hydroxymethylene-1,1-bisphosphonates (N-HMBPs) for conjugation strategies.

Graphical abstract: Synthesis of new alendronate analogs for bone-targeted drug delivery strategies

Supplementary files

Article information

Article type
Paper
Submitted
29 Oct 2023
Accepted
18 Dec 2023
First published
19 Dec 2023

New J. Chem., 2024,48, 1436-1442

Synthesis of new alendronate analogs for bone-targeted drug delivery strategies

N. Guedeney, J. Deschamp, T. Legigan, M. Monteil, E. Migianu-Griffoni and M. Lecouvey, New J. Chem., 2024, 48, 1436 DOI: 10.1039/D3NJ04980A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements